-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Upgrades Capricor Therapeutics to Buy, Announces $25 Price Target

Benzinga·11/11/2026 20:46:54
Listen to the news
Jones Trading analyst Catherine Novack upgrades Capricor Therapeutics (NASDAQ:CAPR) from Hold to Buy and announces $25 price target.